Enhanced red blood cell (RBC) aggregation has an adverse effect on microcirculatory blood flow and tissue oxygenation. It has been previously shown that obesity is associated with increased RBC aggregation. The objectives of the present study were to further characterize obesity-related RBC aggregation and to examine whether the enhanced aggregation is a plasma-or cellular-dependent process. METHODS: Obese (body mass index (BMI) ¼ 4076.3 kg/m 2 , n ¼ 22) and nonobese (BMI ¼ 2473.4 kg/m 2 , n ¼ 18) individuals were evaluated for inflammation markers and aggregation parameters. Aggregation parameters were derived from the distribution of RBC population into aggregate sizes, and from the variation of the distribution as a function of flow-derived shear stress, using a cell flow properties analyzer. To differentiate plasmatic from cellular factors, we determined the aggregation in the presence of autologous plasma or dextran-500kDa and calculated the plasma factor (PF) in the obese group. PF ranges from 0 to 1. When the PF ¼ 1, the aggregation is all due to plasmatic factors, when PF ¼ 0, the altered aggregation depends entirely on cellular factors, whereas 0oPFo1 reflects the joint contribution of cellular and plasmatic factors. RESULTS: Obese subjects had relatively larger aggregates that were more resistant to dispersion by flow. The calculated PF in the obese group was 0.9, indicating a pronounced contribution of plasma to RBC aggregation in obesity. DISCUSSION: Our results suggest that obese individuals present pathological plasma-dependent RBC aggregation, which is probably triggered by plasma macromolecules associated with the inflammatory response. These findings impact the future attempts to develop strategies aimed at attenuation of the enhanced RBC aggregation in obese individuals.
Introduction
Previous studies have shown that increased red blood cell (RBC) aggregation may cause microcirculatory disorders including decreased RBC deoxygenation, 1 reduced capillary perfusion, ischemia, local metabolic acidosis, degeneration of vascular wall and tissue infarction. 2, 3 We have recently shown, using the erythrocyte adhesiveness aggregation test, that obesity is associated with increased tendency of RBC to adhere to each other and form aggregates. 4 RBC aggregation depends on opposing factors: the repulsive force between the negatively charged cells and the disaggregating shear force generated by blood flow, on the one hand, and the cell-tocell adhesion induced by plasma proteins, on the other. [5] [6] [7] [8] Thus, RBC aggregation is dependent on both cellular (intrinsic) and plasmatic (extrinsic) factors. The objectives of the present study were to further characterize obesityrelated RBC aggregation, especially with regard to the aggregate size and strength, and to examine whether the enhanced aggregation is a plasma-or cellular-dependent process.
In the present study we used a cell flow properties analyzer (CFA) to monitor RBC aggregation by direct visualization of the aggregation process under controllable shear stress in a narrow gap (up to 40 mm) flow chamber. 9 The CFA analyzes the aggregate size distribution as a function of shear stress and can provide various measures of RBC aggregation, for example, the distribution of RBC population into aggregate sizes, the shear stress required to disperse the aggregates and the aggregation kinetics. 10 In addition, we used this method to determine the relative contribution of plasmatic factors to the observed aggregation. 11, 12 We found that obese individuals present larger aggregates that are more resistant to dispersion by flow compared with nonobese individuals, and that the plasma is a significant contributor to the enhanced RBC aggregation seen in obesity. These findings may shed light on the contribution of microcirculatory disorders to obesity-related complications.
Methods

Study population
The study was approved by the Local Ethics Committee and all participants signed an informed consent. Included were 40 individuals that were either referred for evaluation at the 'Obesity Center' or came for a general medical examination at the outpatient clinic at the Tel-Aviv Sourasky Medical Center. Five individuals have participated in our previous study as well. 4 Exclusion criteria were any underlying inflammatory or malignant conditions, surgical or invasive procedure or cerebrovascular or myocardial infarction within 6 months prior to the recruitment. In addition, we excluded individuals who either initiated or had to modify drug therapy within 3 months prior to their recruitment. Individuals treated with any steroidal or nonsteroidal antiinflammatory medications, except for low-dose aspirin (100 mg/day), were also excluded from this protocol.
Laboratory methods
Markers of the acute phase response. The erythrocyte sedimentation rate (ESR) was measured using the method of the International Committee for Standardization in Hematology, 13 fibrinogen concentrations were determined by the method of Clauss 14 and high-sensitivity C-reactive protein (hs-CRP) was measured using the Boering BN II nephelometer according to Rifai et al.
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RBC aggregation
Preparation of RBC suspension for determination of RBC aggregation. Samples from venous blood were drawn from the antecubital vein and collected into EDTA containing Vacutainers. The RBC were isolated by centrifugation (2000 rpm for 10 min), washed with PBS, pH 7.4, and resuspended to the desired hematocrit in either autologous plasma or PBS supplemented with 1% bovine serum albumin (Sigma, St Louis, MO, USA) and 0.5% dextranF500 kDa ((dextran-500), Pharmacia Biotech, Uppsala, Sweden) to induce aggregation. Dextrans have been used extensively for studying RBC aggregation, [9] [10] [11] [12] and it was previously shown that 0.5% of dextran-500 induces the formation of RBC aggregates similar in size and shape to those formed in plasma. 16 Determination of RBC aggregation. RBC aggregation was measured in either autologous plasma or standard dextran solution, as noted above. All aggregation measurements were conducted within 2 h after venipuncture. The aggregability of RBC was studied using the CFA that was designed and developed in the laboratory of S Yedgar, as previously described. [9] [10] [11] [12] 16 Briefly, RBC suspension in either autologous plasma or dextran solution was prepared at 6% hematocrit. The suspension was then introduced into the flow chamber, connected to a pump exerting laminar flow, and to a pressure transducer that enables the control of shear stress during the experiment. The RBC dynamic organization (aggregation/disaggregation) in the flow chamber was directly visualized and recorded through a microscope connected to a charge-coupled device (CCD) video camera that transmitted the RBC images to a computer, providing parameters of RBC aggregation. The CFA provides the aggregate size distribution as a function of shear stress, from which various parameters of the aggregation can be derived.
In the present study we used previously described measurements to evaluate both the extent of aggregation (eg, aggregate size, the fraction of aggregated RBC) and the strength of intercellular interaction, as expressed by the aggregate resistance to disaggregation by flow. 12 Overall, the following parameters were examined in nonobese and obese subjects.
Small, medium and large aggregate fractions. We measured the distribution of the RBC population according to aggregate size ranges, that is, the erythrocyte fraction (in %) found in small, medium and large aggregates (SAF, MAF and LAF, respectively), referring to size ranges of 1-4, 5-32, and 33 or more RBC/aggregate, respectively. These ranges were chosen because aggregates of up to 4 RBC are usually in the form of linear rouleaux, aggregates of 4-32 RBC will include branched rouleaux, and larger aggregates tend to form rouleaux networks. 12 In normal subjects, large aggregates usually do not exist, thus the existence of LAF may reflect abnormal, pathological aggregation.
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Area under the curve. The area under the curve (AUC) of each aggregation parameter as a function of shear stress was determined for average aggregate size (AAS), SAF and LAF (defined above). The wall shear stress taken for these calculations ranged from 0.15 to 4.0 dyne/cm 2 . At the latter, normal RBC are singly dispersed. 9, 12 These indexes have been previously found to represent clinically relevant RBC aggregation in various pathological conditions.
Assessment of the plasma factor in RBC aggregation. As noted before, the variation in actual RBC aggregation in the blood could result from contributions of cellular, plasmatic or both factors. The identification of these factors is of clinical relevance with possible implications for therapeutic strategies. To distinguish between RBC intrinsic-cellular factors and the actual aggregation in plasma, aggregation
Red blood cell aggregation in morbid obesity D Samocha-Bonet et al was compared in autologous plasma and in standard dextran solution. We calculated the plasma factor (PF) as follows:
where DAg ¼ mean(Ag Obese )-mean(Ag Nonobese ), that is, the difference between mean RBC aggregation in the obese group and the mean RBC aggregation in the nonobese group, (FP ¼ full plasma, Dex ¼ dextran solution). Hence, DAg Dex ¼ |mean(Ag Obese )Àmean(Ag Nonobese )| in dextran solution, and DAg FP ¼ |mean(Ag Obese )-mean(Ag Nonobese )| in autologous plasma. Obviously, DAg FP ZDAg Dex , because the determination of aggregation in full plasma includes both cellular and plasmatic factors. Accordingly, 0rPFr1. When PF ¼ 0, there is no plasmatic contribution to the aggregation, meaning the altered aggregation depends entirely on cellular factors. When PF ¼ 1, the altered aggregation is all due to plasmatic factors, 9, 12 whereas 0oPFo1 reflects the joint contribution of cellular and plasmatic factors.
Statistical analysis
The results are presented as mean71 s. linear regression was performed with AUC LAF as the dependent variable and various atherothrombotic risk factors as independent variables. The multiple linear regression was carried out in a stepwise algorithm to avoid co-linearity, with an entry probability value criterion of 0.05 and a removal probability of 0.1. In addition, we performed forward and backward regressions to validate the results. P-values were considered significant when o0.05. Statistical calculations were performed using the SPSS statistical package (SPSS Inc., Chicago, IL, USA).
Results
The study population was divided according to BMI. Individuals with BMI o30 kg/m 2 were considered nonobese (n ¼ 18), whereas those with BMI Z30 kg/m 2 were considered obese (n ¼ 22; BMI ¼ 2473.4 and 4076.3 kg/m 2 , respectively). There were 13 male and 27 female participants and their characteristics are summarized in Table 1 . In total, 27 and 22% of the obese and nonobese individuals were smokers and one obese individual had a past history of myocardial infarction. No individual had a history of stroke or peripheral artery disease. Five obese and three nonobese individuals received antihypertensive medications, five obese and three nonobese subjects received low-dose aspirin, six obese and two nonobese individuals received statins, one obese patient was treated with hormone replacement therapy and four nonobese individuals were on oral contraceptives. One obese individual suffered from non-insulin dependent diabetes, for which he was treated with an oral hypoglycaemic agent.
Highly significant differences between the study groups were noted in all evaluated markers of inflammation (Table 1 ). In addition, significant differences were noted regarding the fasting blood glucose level and serum highdensity lipoprotein-cholesterol (HDL-c) between the study groups ( Table 1) . We found no significant differences in all aggregation parameters between males and females and between smokers and nonsmokers (results not shown).
Indexes of RBC aggregation Highly significant differences in RBC aggregation parameters were measured in autologous plasma between the study groups ( Figure 1, Table 2a ). However, there were no significant differences in all RBC aggregation parameters in the dextran solution between the study groups, indicating similar contribution of cellular factors to aggregation in obese and nonobese subjects (Table 2b) . Notably, large aggregates are mainly formed in obese subjects when examined in autologous plasma (Table 2a and Figure 1) . Complementarily, RBC from nonobese individuals form relatively more small aggregates and single cells, when examined in autologous plasma (Table 2a) . The pathological RBC aggregation in the obese group, in the presence of autologous plasma, is further manifested by the integrative measures of AAS and LAF as a function of shear stress (AUC AAS and AUC LAF , respectively), which reflect the strength of the formed aggregates (Table 2a) . Specifically, Red blood cell aggregation in morbid obesity D Samocha-Bonet et al the AUC LAF , which was 3.5-fold higher in the obese, compared to the nonobese group (Table 2a) , indicating relatively larger aggregates that are more resistant to dispersion by flow in obese subjects.
Association of RBC aggregation parameters with obesity and inflammation indexes
Obesity is closely associated with the inflammatory response 17, 18 as presented in the positive correlations found between obesity indexes (measured as BMI and waist circumference) and all measured inflammation markers (Table 3) . Furthermore, aggregation parameters measured in autologus plasma correlated with both obesity and inflammation indexes (Table 3) . To assess the relation of the formation of strong large aggregates with BMI we transformed both these variables to categorical variables and performed a w 2 test (Table 4) . It can be seen that 89% of the strong large aggregates were found in the obese group, compared with 11% in the nonobese group. Moreover, we evaluated the contribution of various risk factors, including LDL-cholesterol, blood glucose, hs-CRP, smoking status, as well as BMI, to the formation of strong large aggregates (measured as AUC LAF ), using a multiple linear regression analysis (Table 5 ). It can be seen that BMI was the only significant contributor, explaining 31% of the model. All other candidates for the regression model were excluded, as they did not reach statistical significance.
Contribution of PF to RBC aggregation
The calculated contribution of PF to the elevated aggregation in the obese group was 0.9, suggesting that the plasma was the predominant contributor to the pathological RBC aggregation in obesity.
Discussion
Pathological RBC aggregation is characterized by strong intercellular interactions and may affect flow dynamics, mainly within the microcirculation, where shear stress is low. The vessels most likely to be affected by RBC aggregation are the postcapillary venules, where vessel diameter is large enough and shear stress is low enough to allow aggregation.
2 Figure 1 Images of red blood cell organization in autologous plasma in nonobese (a) and obese (b) subjects at 0.15 dyne/cm 2 , visualized through a microscope connected to a charge-coupled device video camera (for detailed information, see Methods). While red blood cells from a nonobese individual form mostly linear rouleaux and small aggregates (a), red blood cells from an obese individual form mainly large clusterous aggregates (b). Red blood cell aggregation in morbid obesity D Samocha-Bonet et al
Recently, it has been shown that the induction of increased RBC aggregation in an in vivo animal model resulted in an increment of arterial blood pressure, accompanied by a decrease in the expression of endothelial nitric oxide synthase (eNOS). 19 This work emphasizes the potential role of enhanced RBC aggregation in the induction of a major atherothrombotic risk factor. In this context, it should be noted that several cardiovascular pathologies are associated with an enhancement of RBC aggregation, including hyperlipoproteinemia, 20,21 diabetes mellitus, 22 hypertension, 23 unstable angina and acute myocardial infarction. 12 Furthermore, obesity is associated with both traditional atherothrombotic risk factors 24 and inflammation. 17, 18 In the present work, we studied the actual RBC aggregation in plasma, which is affected from the overall cellular and plasmatic factors. Moreover, part of the participants in our cohort, especially obese individuals, were treated with medications with potential antiaggregatory 25, 26 and antiinflammatory activities. 27 Nevertheless, obese individuals presented pathological RBC aggregation as compared with nonobese individuals, similar to our findings in individuals with various atherothrombotic risk factors. 27 Previously, obesity has been reported to alter erythrocyte rheological properties 28, 29 and to associate with increased RBC aggregation. 4 In the present study, we found a predominant role of the plasma in the pathological aggregation found in obese individuals. The plasma of obese individuals was a powerful stimulator to the aggregation, producing large clusters of aggregates that were resistant to dispersion by flow. Several plasma components might play a role in this phenomenon. Specifically, obesity is accompanied by increased circulating CRP and fibrinogen concentrations. 4, 17, 18, 30 The latter is a well-characterized RBC aggregation inducer, [31] [32] [33] [34] [35] [36] either through a nonspecific mechanism 31, 32 or by specific binding of fibrinogen to RBC surface membranes, 36 and thus bridging between the cells.
Furthermore, CRP has been shown to correlate with indexes of RBC aggregation as well. 4, 12, 20 A previous work by Weng et al 37 has shown that increased CRP concentrations elevated RBC resistance to shear in vitro; however, CRP concentrations might merely reflect the inflammatory state and thus 34 We found that fibrinogen was the most significant and dominant inflammation-sensitive protein contributing to the enhancement of RBC aggregation, while IgG contributed to a further tendency of the cells to aggregate. The complex interactions between these macromolecules, as well as albumin, in the formation of RBC aggregates were demonstrated recently in an in vitro model by our group. 35 Furthermore, altered glucose and lipoprotein concentrations are also typical to obesity; thus, we evaluated the contribution of LDL and glucose levels to the pathological formation of large and resistant RBC aggregates. We found that neither of these candidates were significant contributors to the phenomenon, as have been found previously. 4, 33, 34 Consequently, the milieu of inflammation-sensitive proteins and adhesive macromolecules, specifically fibrinogen, has a dominant role in maintaining the pathological RBC aggregation found in obese individuals and described in the present study. The present observation emphasizing potential pathophysiological interest is that obese subjects form greater proportion of large aggregates than nonobese individuals. In light of the occlusive potential, the large RBC aggregates are of special importance. Furthermore, we found that RBC aggregates originating from obese patients are relatively more resistant to dispersion by shear stress, implying potential hemodynamic disorders in obesity.
In conclusion, in the present study we have demonstrated that not only do obese individuals present enhanced RBC aggregation, but the aggregates formed are larger and more resistant to dispersion by flow. This phenomenon is predominated by plasma. The nature of the plasmatic components involved in the formation of RBC aggregates has been clarified, at least in part, by several groups of investigators, including ours, during recent years. Future studies aimed at reducing RBC aggregation observed in obese individuals, by life style modifications or therapeutic interventions, 36 are required.
